New Regulatory Body Set To Transform Britains Wine Investment Industry

NFIB and WIA to Provide Better Protection for Wine Investors

Millions of Britons enjoy drinking it and many now see it as a long-term investment. Unfortunately, fine wine has also become a focus for fraudsters who trick investors into buying wines or vineyards that bear little resemblance to what they see in the prospectus, or may not even exist. The increasing number of such rorts in Britain has led to calls for action to be taken to protect investors and to increase consumer confidence in fine wines. In the upshot, the UKs National Fraud Intelligence Bureau (NFIB) is joining forces with the newly-formed Wine Investment Association (WIA) to tackle the problem.

On 14 February 2013, the NFIB and the WIA jointly announced the launch of the new self-regulatory body which will aim to transform the growing wine investment industry by providing better protection for investors in the UK. The WIA has been formed by leading figures from the fine wine investment industry and seeks to support the sector’s growth through voluntary regulation, establishing best practices and setting up processes to identify fraudulent activity.

Director of the NFIB, Det. Supt. Dave Clark, said: “Fraudsters will always follow the money, wine investment is just the latest in a long line of investment opportunities that are being exploited and corrupted to the detriment of the industry as a whole. He added that the NFIB sees the creation of an auditable framework of self-regulation as a step towards maintaining and increasing consumer confidence, while also identifying investment companies which do not operate in accordance with the required high standards.

New Code to Tackle Wine Investment Frauds

Following an extensive consultation period, the WIA has set out the standards and procedures with which its members must comply to remain in good standing. Under the new code of conduct to be drawn up, wine investment firms will undergo stringent audits by accountancy firm Mazars. These will include checks on systems such as stock rotation and to make sure that purchase orders and invoices tally. The director of the WIA, Peter Shakeshaft, revealed that companies which successfully complete the independent audit process commissioned by the newly-formed regulatory body will bear a WIA logo offering consumers a trustworthy safety kitemark. Shakeshaft added: Our industry has been held back far too long by unscrupulous practitioners and issues around fraud. The WIA will really hold the industry to account.

Synthetic Biology Market – Global Industry Analysis, Size, Share And Forecasts, 2012 – 2018

The global market for synthetic biology is estimated to grow to $4.5 billion over the year 2015 owing to the developments in fields like biomedicine, biopharmaceutical synthesis, energy and environment, biosecurity, sustainable chemical segment, and biomaterials. Significant investments by major companies and emergence of new players in the market are also expected to boost the growth of this industry.

Browse : Synthetic Biology Market

.
Synthetic biology is the fastest growing segment of the biotechnology field having number of applications. Synthetic biology provides significant number of near future commercial opportunities. Despite its emerging status, the list of applications is continuously growing. Some of these major applications include chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms among others.

Current developments in technologies like DNA synthesis and sequencing, specialty media, and bioinformatics, and the need for renewable feedstock are driving the market for synthetic biology. Rapid developments in this field are creating unique market opportunities and contributing to the growth of this field.

Synthetic biology is gaining tremendous recognition as a transformative technology as it has the ability to address food storage and security issues as well as handle other threats like climate change, energy shortage, and water deficits.

This research report is a comprehensive analysis of current industry trends, industry growth drivers, restraints, industry capacity, market structure, and market projections for upcoming years. The report also includes analysis of technological developments in the market, Porters five force model analysis, and complete company profiles of top industry players.
It provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis.
.
Browse : Synthetic Biology Industry

.
Major Players

Major players dominating this market are Amyris Biotechnologies Inc., ATG Biosynthetics GmbH, Blue Heron Biotechnology Inc., Chromatin Inc., Draths Corp., febit Synbio GmbH, GENEART AG, GenScript USA Inc., Joule Biotechnologies Inc., LC Sciences, LS9 Inc., OPXBIO Inc., Solazyme Inc., Sloning BioTechnology GmbH, Synthetic Genomics Inc., Verdezyne Inc, and others.

Read More :